We are live on ! Find out more
EDIT icon

Editas Medicine

194 hedge funds and large institutions have $780M invested in Editas Medicine in 2018 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 57 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more call options, than puts

Call options by funds: $20.3M | Put options by funds: $18.2M

2.45% more ownership

Funds ownership: 69.66%72.11% (+2.4%)

8% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 36

9% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 57

3% less funds holding

Funds holding: 199194 (-5)

26% less capital invested

Capital invested by funds: $1.06B → $780M (-$277M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
194
Holders Change
-5
Holders Change %
-2.51%
% of All Funds
4.32%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
33
Increased
52
Reduced
57
Closed
36
Calls
$20.3M
Puts
$18.2M
Net Calls
+$2.16M
Net Calls Change
-$2.06M
Name Holding Trade Value Shares
Change
Change in
Stake
CBT
226
Capital Bank & Trust
California
-$1K -24 Closed
Fifth Third Bancorp
227
Fifth Third Bancorp
Ohio
+$54 +2 New

EDIT Hedge Fund Activity: Q4 2018 in Review

194 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2018, worth a combined $780M — down 26% from $1.06B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of EDIT and 33 opened new positions — a net loss of 3 holders — while 57 trimmed existing stakes and 52 added.

The largest buyer was Ontario Teachers' Pension Plan Board, opening a new position worth an estimated $23.6M. The largest seller was State Street, cutting an estimated $21M.

  • 194 institutional investors held Editas Medicine (EDIT) as of Q4 2018, down from 199 in Q3 2018.
  • Funds reported $780M of Editas Medicine stock for Q4 2018, down 26% quarter-over-quarter.
  • 33 funds opened new Editas Medicine positions in Q4 2018 and 36 closed out, a net change of -3 holders.
  • The largest Editas Medicine buyer in Q4 2018 was Ontario Teachers' Pension Plan Board, an estimated $23.6M added.
  • The largest Editas Medicine seller in Q4 2018 was State Street, an estimated $21M sold.

Based on aggregated 13F filings for Q4 2018.